Key Insights

Highlights

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT01132859RecruitingPrimary

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

NCT03236480Unknown

The Gut-lung Axis in Chronic Obstructive Pulmonary Disease

Showing all 2 trials

Research Network

Active Sponsors

  • Ningde City Hospital, Fujian, China1
  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • Peking University People's Hospital1

Top Investigators

Related Conditions

  • Blood Specimen Collection1
  • Immune System Processes1
  • Microbiota1
  • Metabolism1
  • Pulmonary Disease Chronic Obstructive1

Activity Timeline